The future of drug discovery.

Critical Outcome Technologies welcomes Mr. Justin Leushner to the Business Advisory Board

jan. 26th, 2006

The management team of Critical Outcome Technologies is pleased to welcome Mr. Justin Leushner, (BSc. MBA) to the Business Advisory Board, effective immediately.

In addition to an MBA from the Ivey School of Business at the University of Western Ontario, Mr. Leushner holds a B.Sc. in Cell Physiology/Genetics from the University of British Columbia and many technical designations in Forensic Science and Molecular Biology. He was operationally responsible for developing a national Molecular Diagnostics program for Canada's largest life sciences company MDS Inc. Mr. Leushner has also been involved with Life Sciences Venture Capital, working as a business analyst and liquid portfolio advisor.